slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
794 KRW | -0,50% | +6,01% | -16,33% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Clinical Trial Agency Services
58,1
%
| 3 034 | 67,5 % | 2 715 | 58,1 % | -10,52% |
Clinical Laboratory Animals Goods
22,3
%
| 1 462 | 32,5 % | 1 042 | 22,3 % | -28,71% |
Manufactured Product
19,7
%
| - | - | 919 | 19,7 % | - |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 4 496 | 100,0 % | 4 676 | 100,0 % | +4,01% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Young-Jun Son
CEO | Chief Executive Officer | 52 | - |
Young-Gil Lee
DFI | Director of Finance/CFO | 63 | - |
Sang-Cheol Lee
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Young-Jun Son
CEO | Chief Executive Officer | 52 | - |
Young-Gil Lee
DFI | Director of Finance/CFO | 63 | - |
Sang-Cheol Lee
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Chang-Gi Heo
BRD | Director/Board Member | 49 | - |
Sang-Hwan Hyeon
BRD | Director/Board Member | 53 | - |
Ik-Jin Yoon
BRD | Director/Board Member | 62 | - |
Hyun-Woo Lee
BRD | Director/Board Member | 61 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 716 352 | 4 142 352 ( 72,46 %) | 0 | 72,46 % |
Aandeel B | 0 | 638 295 | 0 | 0 |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,33% | 1,84 mln. | |
+8,21% | 3,7 mld. | |
+14,38% | 2,54 mld. | |
-32,34% | 1,23 mld. | |
-24,96% | 686 mln. | |
-23,20% | 658 mln. | |
-42,42% | 639 mln. | |
0,00% | 75,31 mln. | |
-4,38% | 73,41 mln. |
- Beurs
- Aandelen
- Koers A215570
- Onderneming Cronex.Co.,Ltd